Stock Update (NASDAQ:CME): Douglas Diamond to receive CME Group-MSRI Prize in Innovative Quantitative Applications

[PR Newswire] – CHICAGO, Jan. 26, 2016 /PRNewswire/ — CME Group, the world’s leading and most diverse derivatives marketplace, and the Mathematical Sciences Research Institute (MSRI) announced Douglas Diamond, Professor of Finance at the University of Chicago, as the 2015 recipient of the CME Group-MSRI Prize in Innovative Quantitative Applications. A ceremony honoring Diamond will take place at CME Group Headquarters on Monday, Feb. 1, at 10:00 a.m. CT and will feature a dynamic discussion on the topic of non-bank runs and financial crises. Diamond, Fischer Black Visiting Professor of Financial Economics at the Massachusetts Institute of Technology (MIT) Sloan School of Management from 2015-2016, and Merton H. Miller Distinguished Service Professor of Finance at the Booth School of Business at the University of Chicago, has done extensive research on this year’s panel topic. Read more on this. CME Group Inc. (CME) , with a current market cap of $29.21B, started trading this morning at $85.25. Shares have traded today between $84.45 and $86.71 per share with the price of the stock fluctuating between $81.87 to $100.87 over the last 52 weeks. CME shares are currently priced at 21.30x this year’s forecasted earnings, which makes them relatively expensive compared to the industry ’s 14.09x earnings multiple for the same period. The company pays shareholders $2.00 per share annually in dividends, yielding 2.36%. Consensus earnings for the current quarter by the 15 sell-side analysts covering the stock is an estimate of $0.90 per share, which would be $0.05 worse than the year-ago quarter and a $0.09 sequential decrease. Furthermore, our analysis shows the full-year EPS estimate to be $3.85, which would be a $0.46 improvement when compared to the last year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $810.77 Million. If realized, that would be a 3.61% decrease over the year-ago quarter. More recently, JP Morgan upgraded CME from Neutral to Overweight (Jan 13, 2016). Previously, BofA/Merrill upgraded CME from Neutral to Buy. Investors should keep in mind is that the average price target is $98.31, which is 15.32% above where the stock opened this morning. See more in (NASDAQ:CME) Similar Articles: Company Update: CME Group Inc (NASDAQ:CME) – CME Group Announces 2016 Annual Meeting Date Stock Update: CME Group Inc (NASDAQ:CME) – CME Group and CFETS Sign Agreement on Cooperation Stock Update: CME Group Inc (NASDAQ:CME) – CME Group earnings rise on increased trading volume